Drug Trial Radar · NCT06319846
Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4)
Last checked: Nov 20, 2026Latest source record: Jul 12, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
4,674
Planned (sponsor's estimate)
Start
Jul 11, 2024
Primary completion
Oct 2025
Study completion Dec 2026
Sponsor
- Lead sponsor
- Beijing Tiantan HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 20, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, double-blind, double-dummy, randomized clinical trial comparing the efficacy and safety of tirofiban versus placebo in preventing recurrence of stroke for patients with intracranial artery stenosis and high-risk acute non-disabling cerebrovascular events.
Conditions
- Ischemic Stroke, Acute
- TIA
- Symptomatic Intracranial Artery Stenosis
Interventions
TirofibanDrug
Initial infusion of tirofiban 0.4μg/kg body weight/minute for 30 minutes (a maximum dose of 1mg) within 24 hours of symptom onset, followed by a continuous infusion of tirofiban 0.1μg/kg body weight/minute for 48 hours.
PlaceboDrug
Initial infusion of saline placebo for 30 minutes within 24 hours of symptom onset, followed by a continuous infusion of placebo for 48 hours.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Any new ischemic stroke at 3-monthTime frame: at 3-month
- Type 3 or 5 bleeding events according to the BARC criteria at 3-monthTime frame: at 3-month
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
The 2nd Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China · Recruiting
People's Hospital of Qihe County
Dezhou, Shandong, China · Recruiting
Liaocheng People's Hospital(Liaocheng Brain Hospital)
Liaocheng, Shandong, China · Recruiting
Third People's Hospital of Liaocheng
Liaocheng, Shandong, China · Recruiting
Yantai Penglai traditional Chinese medicine hospital
Yantai, Shandong, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.